Leanne Kelly - May 14, 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Financial Officer
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 04:07 PM
Previous filing
May 18, 2021
Next filing
Jun 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +70K $0.00 70K May 14, 2021 Common Stock 70K $3.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.